Generics 8

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Trimetazidine dihydrochloride manufacturers

8 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

8 products found

trimetazidine dihydrochloride

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120
This globally competitive organization specializes in formulating a wide range of medications and exports to over 40 countries. Their state-of-the-art manufacturing facilities are strategically located across three cities, adhering to stringent regulatory standards like those set by the EU, UK, and UNICEF. They produce diverse dosage forms including tablets, capsules, creams, ointments, gels, and sterile formulations such as lyophilized products and prefilled syringes. Key therapy areas include complex generics, orphan drugs, and treatments for neglected tropical diseases. The company holds GMP certifications and possesses product patents, emphasizing their commitment to quality and innovation. They actively participate in global initiatives, providing emergency stockpiles for coronavirus treatments and partnering with organizations to address the healthcare needs of Palestinian refugees.

Manufacturer usually replies in 42 days

trimetazidine dihydrochloride

Tablets, extended release (ER) 35mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #557
This organization is a multinational pharmaceutical company dedicated to providing affordable healthcare globally. They offer over 1,500 products across various therapeutic areas including HIV/AIDS, making significant contributions to accessibility in emerging markets like India, South Africa, and the U.S. Their product portfolio encompasses over 50 dosage forms, ranging from prescription medications and OTC drugs to potentially medical devices and supplements. They prioritize GMP certifications and hold patents for key products. Their commitment to affordability and inclusiveness has earned them recognition as a leader in global health initiatives.

Manufacturer usually replies in 38 days

trimetazidine dihydrochloride

Tablets 20 mg, 35 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21424

Established in 1987, this Manufacturer is a fully integrated biopharmaceutical entity specializing in human insulin, analogue insulin, and GLP-1 agents, offering both drug substances and formulations. As a CTD dossier owner and manufacturer, it provides comprehensive services from proof of concept to commercial scale, including yield optimization and contract manufacturing in vials, ampoules, cartridges, and disposable pens. Operating two manufacturing facilities—one in Taloja, Navi Mumbai, certified with WHO-GMP compliance to PIC standards, and another in Pune adhering to European Medicines Evaluation Agency (EMEA) and US FDA standards—the Manufacturer ensures high-quality production. With a workforce of approximately 500 employees, its products are accredited in over 30 countries and regions worldwide. As a GMP manufacturer, it maintains stringent quality standards across all operations. Committed to global health, this CTD dossier owner and manufacturer continues to expand its presence in regulated markets

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.